STOCK TITAN
  1. Home
  2. News
  3. HTGC

Hercules Capital Inc - HTGC STOCK NEWS

Welcome to our dedicated news page for Hercules Capital (Ticker: HTGC), a resource for investors and traders seeking the latest updates and insights on Hercules Capital.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Hercules Capital's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Hercules Capital's position in the market.

News
Hercules Capital, Inc. Prices Upsized Public Offering of Common Stock
Rhea-AI Summary
Hercules Capital, Inc. (NYSE: HTGC) announces upsized public offering of 6,500,000 shares of common stock with an option for an additional 975,000 shares. The offering is expected to close on August 10, 2023. Net proceeds will be used for investments, debt repayment, and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.22%
Tags
offering
-
News
Hercules Capital, Inc. Announces Public Offering of Common Stock
Rhea-AI Summary
Hercules Capital, Inc. (HTGC) plans to make a public offering of 6,000,000 shares of its common stock, with an option to purchase up to an additional 900,000 shares. The net proceeds will be used for investments in debt and equity securities, repayment of indebtedness, and general corporate purposes. The offering is made pursuant to an effective shelf registration statement filed with the SEC on December 17, 2021.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.22%
Tags
offering
-
News
Hercules Capital Reports Second Quarter 2023 Financial Results
Rhea-AI Summary
Hercules Capital, Inc. (NYSE: HTGC) announced its financial results for Q2 2023. Total investment income increased by 61.2% YoY to $116.2 million. Net investment income (NII) was $75.7 million, or $0.53 per share, an 88.6% YoY increase. Total gross fundings for 1H 2023 reached $834.8 million, a 5.6% YoY increase. The company increased its base cash distribution to $0.40 per share, with Q2 2023 NII providing 132% coverage. Undistributed earnings spillover amounted to $148.1 million, or $1.02 per share. Assets under management increased by 19.5% YoY to approximately $4.0 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
earnings
News
Hercules Capital Increases Its Total Cash Distribution to $0.48 per Share for the Second Quarter 2023
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.32%
Tags
earnings
-
News
Heron Therapeutics Announces $30 Million Private Placement Financing
Rhea-AI Summary
Heron Therapeutics, Inc. has entered into a securities purchase agreement to sell 20,734,917 shares of its common stock and pre-funded warrants to institutional investors. The purchase price for the common stock is $1.37 per share, while the pre-funded warrants have a purchase price of $1.3699 per warrant. The gross proceeds from the private placement are expected to be approximately $30.0 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.59%
Tags
none
-
News
Hercules Capital Announces Date for Release of Second Quarter 2023 Financial Results and Conference Call
Rhea-AI Summary
Hercules Capital, Inc. has scheduled its second quarter 2023 financial results conference call for August 3, 2023, at 2:00 p.m. PT. The company will release its financial results after market close on the same day. A live webcast of the conference call will be available on the investor relations section of the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.21%
Tags
earnings
News
Tipalti Secures $150 Million in Growth Financing from JPMorgan Chase Bank and Hercules Capital
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
none
-
News
Hercules Capital Announces Date of 2023 Annual Meeting of Stockholders
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
none
-
News
Hercules Capital Reports First Quarter 2023 Financial Results
Rhea-AI Summary
Hercules Capital, Inc. reported record Q1 2023 total gross fundings of $476.2 million, total investment income of $105.1 million (up 61.3% YoY), and net investment income (NII) of $65.5 million (up 83.0% YoY). Q1 2023 NII provides 123% coverage of the base cash distribution. Hercules had approximately $1.0 billion of available liquidity at the end of the quarter. The company also established a new institutional private credit lending program and saw a 33.2% increase in assets under management to over $3.9 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
earnings
News
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2023
Rhea-AI Summary
Hercules Capital, Inc. announces a first quarter 2023 total cash distribution of $0.47 per share. The distribution is comprised of a $0.39 per share base distribution and an $0.08 per share supplemental distribution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.44%
Tags
none
Stock HTGC logo
Hercules Capital Inc

NYSE:HTGC

HTGC Rankings

#1556 Ranked by Market Cap
#1771 Ranked by Stock Gains
#1519 Ranked by Dividends

HTGC Stock Data

2.88B
143.98M
1.88%
26.91%
3.52%
Securities and Commodity Exchanges
Finance and Insurance
Link
US
Palo Alto

About HTGC

hercules technology growth capital, inc. (nyse: htgc) ("hercules") is the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and energy & renewable technology industries, at all stages of development. since inception (december 2003), hercules has committed more than $4.6 billion to over 300 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing. at hercules, we provide venture debt to entrepreneurial companies at all stages of development to further their growth and help them achieve key milestones. in addition to the capital we provide, many times the access to our network of contacts and simple business advice can prove to be equally as valuable. we understand the importance of these intangibles because we, like the companies which choose hercules, also come from an entrepreneur